# A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

> **NCT04769869** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 110 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD4604 for inhalation via DPI
- **DRUG:** Placebo for AZD4604 for inhalation via DPI
- **DRUG:** AZD4604 for IV administration
- **DRUG:** AZD4604 for oral administration
- **DRUG:** AZD4604 for inhalation via DPI

## Key facts

- **NCT ID:** NCT04769869
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-08
- **Primary completion:** 2023-01-24
- **Final completion:** 2023-01-24
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769869, "A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04769869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*